Maynard, MA – JM Coull (JMC), recently completed renovations for Quanterix’s new headquarters on Middlesex Turnpike in Billerica. The two-story, 90,000 sf facility combines operations from the company’s previous Lexington and Billerica sites, and includes labs, expanded manufacturing areas, offices, a café, and a fitness facility. The new building provides the necessary space to accommodate Quanterix’s continued growth as a leader in biomarker technology. JMC worked with Gorman Richardson Lewis Architects and Fitzemeyer & Tocci on the project. The project’s preconstruction phase was completed under JMC’s two-part StartSmart® Preconstruction Program.
Quanterix develops and markets revolutionary digital biomarker analysis devices used by researchers to closely examine critical biomarkers in numerous therapeutic areas, such as oncology, neurology, cardiology, inflammation, and infectious diseases. The company counts biopharma firms such as Pfizer, Merck, Shire, Sanofi, and Biogen among its customers.
Heather Waice, JMC’s project manager, comments, “Quanterix does amazing work that ultimately helps patients with serious and life-threatening diseases. To play a small role in that, by providing Quanterix with an efficient space in which to do this work, is very gratifying.”
JM Coull is an award-winning construction manager, design builder, and general contractor specializing in solutions for the life sciences, advanced technology, corporate/industrial, healthcare, and education markets. The firm’s proven StartSmart Preconstruction Program seeks to minimize front-end investment while maximizing return on investment. JMC is based in Maynard, MA and performs work throughout New England.

Media Contact:
Laura Burch
(978) 461-0330
[email protected]